YBT-19978-53804
2 vaccinations
6 coded responses
14 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 104 / NY
- Registered
- 2021-05-12
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-13
Dose 1 — Moderna
-
2021-05-12
Registered in v-safe
-
2021-05-12
Dose 2 — Moderna
- 2021-05-12
-
2021-05-13
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia, Asthenia, Injection site pain, Paraesthesia — Feeling: Poor · Site: Swelling, Itching · Chills · Be unable to do your normal daily activitiesFree text: Intense pain in my opposite shoulder to injection site, similar to a separated shoulder. Tingling in fingers weakness in grip, general weakness in armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling, Itching · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-19
-
2021-06-02
Survey response — day 21, dose 2MedDRA: Chills, Headache, Lethargy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Lethargy headache and chillsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-16
-
2021-06-23
Survey response — day 42, dose 2MedDRA: Disturbance in attention, Gastrointestinal disorder — Feeling: Poor · Be unable to work or attend schoolFree text: Stomach issues inability to concentrateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-11
Survey response — 3 months, dose 2MedDRA: Cognitive disorder, Lethargy — Feeling: FairFree text: Lethargy constant and draining of mental acuityMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-12
Survey response — 6 months, dose 2MedDRA: Brain fog, Disturbance in attention, Lethargy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Extreme lethargy inability to focus, "Scatterbrained"MedDRA releases: 2024-11 · check-in free text available
-
2022-05-12
Survey response — 12 months, dose 2MedDRA: Disturbance in attention — Feeling: Fair · Be unable to do your normal daily activitiesFree text: I am having a very difficult time focusing such as on tasks at hand i.e. reading and writing. Cannot stay focused.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Moderna | |
| 2 | 2021-05-12 | Moderna |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Intense pain in my opposite shoulder to injection site, similar to a separated shoulder. Tingling in fingers weakness in grip, general weakness in arm
Release 8 — day 21, dose 2
Symptoms: Lethargy headache and chills
Release 9 — day 42, dose 2
Symptoms: Stomach issues inability to concentrate
Release 9 — 3 months, dose 2
Symptoms: Lethargy constant and draining of mental acuity
Release 10 — 6 months, dose 2
Symptoms: Extreme lethargy inability to focus, "Scatterbrained"
Release 11 — 12 months, dose 2
Symptoms: I am having a very difficult time focusing such as on tasks at hand i.e. reading and writing. Cannot stay focused.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cognitive disorder | ✓ | · | ✓ |
| SD | Disturbance in attention | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lethargy | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release